BeOne Medicines (ONC) Enterprise Value Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.42% |
| Dec 31, 2025 | -73.08% |
| Sep 30, 2025 | -49.41% |
| Jun 30, 2025 | -6.30% |
| Mar 31, 2025 | 9.91% |
| Dec 31, 2024 | 17.23% |
| Sep 30, 2024 | 14.88% |
| Jun 30, 2024 | 26.26% |
| Mar 31, 2024 | 27.12% |
| Dec 31, 2023 | 30.00% |
| Sep 30, 2023 | -263.95% |
| Jun 30, 2023 | 38.35% |
| Mar 31, 2023 | -101.92% |
| Dec 31, 2022 | -102.24% |
| Sep 30, 2022 | 77.73% |
| Jun 30, 2022 | -30.16% |
| Mar 31, 2022 | 34.79% |
| Dec 31, 2021 | 51.79% |
| Sep 30, 2021 | 16.65% |
| Jun 30, 2021 | -143.73% |
| Mar 31, 2021 | -107.54% |
| Dec 31, 2020 | -381.14% |
| Sep 30, 2020 | -1,155.52% |
| Jun 30, 2020 | -191.86% |
| Mar 31, 2020 | -64.97% |
| Dec 31, 2019 | 9.55% |
| Sep 30, 2019 | 73.11% |
| Jun 30, 2019 | 54.58% |
| Mar 31, 2019 | 12.94% |
| Dec 31, 2018 | -29.83% |
| Sep 30, 2018 | -87.31% |
| Jun 30, 2018 | -245.07% |
| Mar 31, 2018 | -198.19% |
| Dec 31, 2017 | -123.56% |
| Sep 30, 2017 | -264.94% |
| Jun 30, 2017 | -73.42% |
| Mar 31, 2017 | -32.46% |
| Dec 31, 2016 | -266.39% |
| Sep 30, 2016 | -641.78% |
| Jun 30, 2016 | -800.85% |
| Mar 31, 2016 | -1,749.52% |